In this paper, we provide a detailed protocol for a model of long bone mechanical marrow ablation in the rodent, including surgical procedure, anesthesia, and pre-and post-operative care. In addition, frequently used experimental end points are briefly discussed. This model was developed to study intramembranous bone regeneration following surgical disruption of the marrow contents of long bones. In this model, the timing of the appearance of bone formation and remodeling is well-characterized and therefore the model is well-suited to evaluate the in vivo effects of various agents which influence these processes. When biomaterials such as tissue engineering scaffolds or metal implants are placed in the medullary cavity after marrow ablation, end points relevant to tissue engineering and implant fixation can also be analyzed. By sharing a detailed protocol, we hope to improve inter-laboratory reproducibility.
Introduction
There are several bone repair models currently in use, including fracture healing, 1,2 marrow ablation, [3] [4] [5] [6] [7] [8] [9] calvarial defect, 10, 11 distraction osteogenesis, 8, 12 segmental replacement 13 and spinal fusion. 14, 15 Model choice depends upon the type of bone formation to be studied, as well as the importance of loadbearing, skeletal region and ability to translate to the clinic. The marrow ablation model is primarily used for two main purposes: (1) as a model for intramembranous bone regeneration 3, 4, 16, 17 and (2) as a model to study implant fixation in orthopedics 9, [18] [19] [20] [21] and dentistry. 22, 23 Therefore, the model is of interest to orthopedic and dental research, including biomaterial specialists, implant designers and molecular biologists as well as the field of regenerative medicine.
Bone regeneration occurs through either the endochondral or the intramembranous bone formation pathway. Endochondral bone forms from a cartilaginous precursor anlagen that is replaced by bone and is essential for most types of fracture repair. 24 Intramembranous bone is formed directly from mesenchymal cell condensations without any cartilage precursor. This latter pathway, although also present in fracture repair, is integral to bone defect repair, distraction osteogenesis and implant fixation. 9, 25, 26 Like nearly all wound repair responses, intramembranous bone formation following marrow ablation has inflammatory, repair and remodeling phases each of which are time-dependent, characterized histologically and genetically. 4 These phases for intramembranous bone formation are distinct from endochondral-based fracture repair. For instance, bone formation following marrow ablation, unlike endochondral-based fracture repair, does not include chondrocytes and lacks collagen type II mRNA expression. 27 The marrow ablation model, used for nearly 70 years, was originally established in 1946 as an experimental model to study marrow regeneration in rabbits. 28 The first marrow ablation procedure used sterile mineral oil to flush out the marrow contents and a rigid metal probe to break-up the intramedullary bone. The debris was then flushed out with sterile saline through holes drilled in the diaphysis. Suva et al. 7 were the first to use a needle to manually disrupt or ablate the marrow contents during marrow ablation surgery. 7 Later the use of a needle was continued, but the use of a dental brush was added to further remove marrow contents, combined with flushing with sterile saline. 29 Our lab first used the Suva et al. 7 method of marrow ablation 7 to study gene expression during intramembranous bone regeneration, 5 and incorporated surgical aspects as used by Bab 6 in both a gene-expression study 4 and a drug treatment study. 3 Our lab and several others have used the marrow ablation model with the addition of an implant to study implant fixation. 4, 9, 18, 30, 31 In addition to providing a specific platform to study postinjury intramembranous bone formation, the mechanical marrow ablation model is a technique that is applicable to clinical medicine. It mimics the surgical process of intramedullary ablation required prior to implant placement during joint replacement surgery in humans. The prevalence of total knee arthroplasty and total hip arthroplasty increased by 6% from 2009-2010. 32 Perhaps, more importantly, the number of people requiring joint replacement is expected to increase by over 100% in the next 15 years and those people needing revision surgery will double by 2026. 33 There is a great need for dental implants as well with about 450 000 osseointegrated dental implants being placed each year. 34 With increased medical need for joint replacement and dental implants, a robust, reproducible pre-clinical model can contribute to testing new therapies and better the understanding of implant healing and physiology. Thus, there is a clear need for standardization of research tools such as the mechanical marrow ablation model.
The mechanical marrow ablation model is an animal model used to study post-injury intramembranous bone repair, biomaterial compatibility and implant fixation. In this paper, we provide a detailed protocol for marrow ablation in mice and marrow ablation with implant placement in rats. Our discussion describes several methods to evaluate the post-ablation bone regeneration and bone-implant contact including microcomputed tomography (mCT), mechanical pull-out testing, histology, dynamic histomorphometry, gene expression and biomarkers. Any of these study end points can be used in this model and may be translatable to clinical measures.
Materials and Methods
Using the team-based approach described here, the femoral marrow ablation surgery takes B1 h for 8 mice (each mouse is anesthetized for about 7 min) and marrow ablation with implant placement in rats takes B1 h for 6 rats (each rat is anesthetized for about 10 min). The length of time is important to track to ensure animals are not under anesthesia for too long.
Pre-operative preparation for marrow ablation Team composition. For optimal surgery outcomes, a six-person surgery team is organized with four work stations ( Figure 1) . In station 1, the technician anesthetizes, prepares the animal for surgery and administers analgesic, antibiotics and fluids prior to surgery; this way the drugs are in the animal's system prior to the start of surgery. In station 2, the surgeon and surgical assistant complete the ablation surgery and, when used, implant or biomaterial placement. In station 3, the wound is sutured by the closer and the closer assistant. The animal is then moved to station 4 for recovery under a heat lamp. Procedures at stations 2 and 3 occur under sterile conditions. A non-sterile assistant is helpful to move animals between stations and to ensure that an anesthetic plane is maintained during surgery.
Preparation. The animals are ordered at least 3 weeks prior to surgery to allow for quarantine which varies per institution and, if necessary, aging. We use this technique on multiple inbred and outbred mouse strains (Jackson Laboratories, Bar Harbor, ME, USA: FVB/NJ, C3H/HeJ, C57Bl/6 J, BALB/cJ and Charles River, Kingston, NY, USA: Swiss Webster) and skeletally mature, 400 g rats (Envigo Medical Laboratory, Madison, WI, USA and Charles River: Sprague-Dawley).
Prior to surgery, surgical supplies are sterilized (see the 'Materials and methods' section). All surgical tools, emesis basins, gauze and drapes are placed on stainless steel trays (organized per surgical station) and wrapped in separate drapes. These packages are secured with autoclave tape and autoclaved on the dry cycle, lasting about 1 h. In total, supplies tend to be autoclaved in 2-3 wrapped packages. Animals are weighed to establish baseline, pre-surgery weights. Pre-surgery weights are used to calculate per animal dosages of any drugs administered as part of the experimental design. For mice and rats buprenorphine (0.05 mg kg À 1 ) can be used Procedure for mechanical marrow ablation in mouse Marrow ablation surgery takes about 8 min per animal. At the first station, the animal is anesthetized; isoflurane gas or ketamine are two options for anesthesia. 35 Test for the withdrawal reflex by pinching the paw of the animal; if there is not a reflexive flexion of the limb, the animal is non-responsive to noxious stimuli and is deeply sedated. Once the animal is safely sedated, the operable leg is prepared for surgery. The operable leg is shaved and then scrubbed with Betadine and 70% ethanol to sterilize the operable region, as reported previously. 4, 9 The animal is moved to the second station on the surgery table and placed on a heating pad to avoid an anesthesia induced drop in body temperature. Careful attention to maintenance of sedation is achieved by periodically repeating the paw pinch test. The animal is draped for surgery. Using aseptic technique, surgery begins with a small longitudinal skin incision along the medial knee joint, B1 cm long, which exposes the 1.5 mm long white patellar tendon running longitudinally superficial to the knee joint (Figure 2a) . A second incision is made deep to the first at the medial border of the patellar tendon. The surgery assistant carefully moves the patellar tendon laterally using Dumont forceps. Note, straighten the knee while moving the tendon laterally to lessen the risk of tearing the tendon from its muscular attachments. The glossy, cartilage-covered distal femoral condyles are now exposed (Figure 2b) . Using a 25 g bevel edge needle or a similar sized drill bit, the surgeon gains access to the medullary canal by repeatedly twisting the needle/bit clockwise and counterclockwise in the femoral intercondylar fossa (Figure 2c) .
To ream the intramedullary contents, a 23 g bevel edge needle or a similar sized drill bit, is placed in the newly formed ablation site. The needle/bit is pistoned in and out of the intramedullary canal and turned clockwise and counter-clockwise. During reaming, the surgeon may feel a 'crunchy' texture as the trabecular bone is broken up. The lesser trochanter is the proximal limit to reaming; progressing proximal to the lesser trochanter risks breaking through the proximal end of the femur. Once the intramedullary contents are sufficiently disrupted the needle/drill bit glides easily in and out of the medullary canal. The ablation site is then flushed with 0.6 ml of warmed sterile saline. The dislodged intramedullary contents are visible flowing out of the ablation site as bright red debris. Flushing is an optional step in the ablation process depending on the desired end points of the experiment. 9 After flushing, the access site can be filled with sterile bone wax closing off the intramedullary canal from the joint space (Figure 2d) . Only a small amount of wax is needed to seal the hole and ebb bleeding. To set the wax in place, use the flat side of the scalpel blade or the back end of the scalpel handle to flatten the wax into place. Finally, wipe the distal femur with a piece of sterile gauze to remove any bone wax fragments.
After marrow ablation, the animal is moved to the third station for wound closure. Sutures are placed internally to reposition the patellar tendon and externally to close the skin. A wound staple is placed over the external sutures to protect them from being chewed or scratched out (Figure 2e ). Care must be taken to avoid clamping the medial saphenous vein within the wound clip, which will result in extensive swelling of the distal limb.
After the wound is closed, the non-sterile assistant moves the animal to the fourth station for recovery. The animal is placed under a heat lamp and recovers from anesthesia. Note, all cage mates should be kept together as to not stress the animals unnecessarily.
Post-operative management and analgesia for mice
On post-operative day 1, antibiotic and analgesic injections are administered subcutaneously to each animal. The same doses are administered as on surgery day. The surgical wounds are checked for any disruption and, if need be, wounds are resutured or wound clips are replaced.
On post-operative day 2, antibiotics are administered subcutaneously to each animal, and if necessary adequate analgesics are administered. Analgesic administration is based on the presence of pain behaviors such as hypo-locomotion, paw lifting, guarding of operated limb and lack of grooming. 36 Our experience is that these behaviors are rare by postoperative day 2.
Pre-operative preparation for marrow ablation and implant placement in the rat
The same pre-operative procedures are followed for rats as for mice. In short, a six-person surgery team is organized. Animals 
Procedure for mechanical marrow ablation and implant placement in rats
Marrow ablation surgery and implant placement takes about 10 min per rat. Rats are anesthetized using an intra-abdominal injection of ketamine (100 mg kg À 1 ) and xylazine (5 mg kg À 1 ). This anesthesia is administered 10 min prior to the start of surgery. Once injected with anesthesia, the rats are prepared for surgery the same way as the mice. The same mechanical marrow ablation steps ( Figure 2) are completed in the rat with one difference. A battery-operated Dremel tool is used to gain access to the medullary canal through the intercondylar fossa. The subchondral bone in rats is hard and the extra force of a drill is needed to penetrate it. The intramedullary canal is reamed by hand using a drill bit with a handle. The exact size of the drill bits depends upon the study. In our lab, we often place a 1.5 mm diameter implant into the reamed cavity and, typically use a 1.6 mm drill bit to break through the subchondral bone and a 1.5 mm drill bit for reaming.
Once the intramedullary canal is reamed, there are different scenarios available depending on end points of the experiment. The first is the same as described above in the mouse model, where the marrow space is flushed and the access site is capped with bone wax. 4 A second scenario involves implant placement whereby the marrow space can be flushed and an implant is hand fit into the canal until it is just deep to the joint surface ( Figure 3) . Depending upon the study, the opening with implant present can be filled with bone wax. 19 A third scenario uses a larger hand drill with a 2.0 mm drill bit to widen the distal 5 mm of the ablation site, followed by implant placement. 20 This widened portion of the canal and the lack of bone wax allow for exposure of the ablation site to the joint space and is used in a model where particles are introduced into the joint space to mimic particle-induced peri-implant osteolysis. 20 Suturing and surgical staple placement are completed in the same manner as in the mouse surgery.
Post-operative management and analgesia for rats
Post-operative care is the same for rats as previously discussed in mice.
Reproducibility of surgery outcomes
We have employed this model in a number of studies. 4, 17, 20, 21, 37, 38 To assess the reproducibility of the model, we re-analyzed outcome data from the mouse marrow ablation model and the rat implant fixation model in which the animal strain, age, sex and experimental end points were comparable. Both mouse studies included females from FVB/NJ and BALB/cJ strains of the same age (10-11 weeks) with the same end point (bone volume/tissue volume, BV/TV) at 7 days post-marrow ablation. For study 1, 17 the within-study coefficient of variation (s.d./mean Â 100%) was 40% for FVB/NJ and 60% for BALB/c. For study 2 (unpublished) the coefficient of variation was 60% for FVB/NJ and 63% for BALB/c. Mean values for BV/TV between study 1 and study 2 were not different for either FVB/NJ (P ¼ 0.977) or BALB/cJ (P ¼ 0.386, Student's t-test). Levene's test for equality of variances showed no significant difference for BV/TV between the two studies (FVB/N, P-value ¼ 0.437 and BALB/c, P-value ¼ 0.311).
Similarly, we compared comparable groups from two studies using the rat implant model, 20, 21 in which 6-month old male Sprague-Dawley rats had implants in place for 12 weeks. In this case, we examined the mechanical strength of implant fixation within the host bone. The within-study coefficient of variation for implant fixation was 29% for control samples and 30% for animals treated with polyethylene particles in the first study 20 and 34% for control and 51% for particle-treated animals in the second study. 21 The mean strength of implant fixation did not vary for the control groups (P-value ¼ 0.065) or particle-treated groups (P-value ¼ 0.283) between the two studies. Levene's test for equality of variances also showed no significant difference in fixation strength between study 1 and study 2 (control groups, P-value ¼ 0.970 and polyethylene treated groups, P-value ¼ 0.557). Together, these analyses indicate that the marrow ablation model is a reproducible surgical model for studying bone regeneration and implant fixation.
Discussion
The outcomes of the mechanical marrow ablation model are reproducible and applicable to the study of intramembranous bone regeneration 3, 4, 16 and bone-implant fixation in orthopedic 9, 18, 19 and dental 22, 23 applications. As a technique with a bone regeneration end point (Figure 4) , the marrow ablation model induces trabecular bone formation within the intramedullary canal in regions that, under normal conditions, lack trabecular bone. The regenerated bone induced by this model is specifically intramembranous bone, 6, 39 as opposed to fracture models where the endochondral bone formation pathway is induced. 40 The marrow ablation model mimics the process of intramedullary reaming for implant placement during joint replacement surgery in humans.
The histological sequence of bone regeneration events from intact (no surgery) through 56 days post-surgery was previously published. 4 We showed that operated limbs exhibit bone formation within the ablated region as early as day 5 in the rat marrow ablation model and day 7 in the mouse marrow ablation model. 4, 17 The newly formed intramedullary bone is resorbed and replaced by lamellar bone (that is, remodeled) beginning around day 10 post-ablation. Typically, the intramedullary contents return to baseline with few remaining trabeculae, if an implant has not been placed, between 28 and 56 days post-ablation. 4 The timing of these histological bone regeneration events is probably condensed in the rodent model compared to patients receiving joint replacements. 4, [41] [42] [43] The model has proven useful in understanding principles relevant to bone regeneration, 4, 17 bone-implant contact 9, 18, 19 and implant fixation. 30 and bone ingrowth. 44 In vivo models are advantageous because of inherent limitation of in vitro studies. Several translational end points that are relevant to tissue engineering and implant fixation can be analyzed after mechanical marrow ablation, including behavioral testing, imaging by mCT, mechanical pull-out testing, histology, dynamic histomorphometry, gene expression and biomarkers.
Behavioral testing
Behavioral testing is important to evaluate the animal for pain or discomfort after the surgical procedure. We assayed ambulation and rearing with a photobeam activity system. This system consists of two sets of photobeams, one to measure ambulation and another to measure rearing. 45 Together these measurements calculate the animal's movements within its environment and are used as a functional test to compare treatments.
Micro-computed tomography
mCT is a non-invasive technique that yields a high-resolution three-dimensional image, in this case, of the post-operative regenerated intramedullary trabecular bone (Figure 4) or periimplant bone within a designated region of interest. Cortical bone geometry can be assessed using mCT as well. Specimens are fixed in either 10% neutral buffered formalin, 70% ethanol, RNAlater or frozen at À 20 1C in saline soaked gauze. Detailed guidelines for scanning rodent bones and the definitions of mCT variables are established and should be followed. 46 Mechanical pull-out testing Mechanical pull-out testing determines the strength of fixation of the implant within the host skeleton. Specimens used for mechanical testing are wrapped in saline soaked gauze and frozen at À 20 1C so that testing of multiple specimens can be organized, although fresh specimens can be tested. End points for mechanical pull-out testing are implant fixation strength and may also include measures of stiffness and energy. 47 Histology and dynamic histomorphometry Histology shows the morphology of the tissue, including cell types present. 4 Most commonly, specimens are fixed in 10% Figure 4 Region of interest, 30-60% of total femoral length. Three-dimensional rendering of post-ablation regenerated trabecular bone in a region that is normally devoid of bone.
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MM Moran et al neutral buffered formalin and prepared for decalcified or undecalcified histology as well as other techniques such as immunohistochemistry 48 for protein expression patterns or in situ hybridization for gene-expression patterns. If animals were administered flurochrome labels, dynamic histomorphometry may also be an end point to measure bone remodeling. 49, 50 Gene expression Gene-expression profiling assesses the relative activity of genes within the tissue being studied and can give insights into molecular mechanisms. 4, 51 Tissues should be harvested and immediately placed in RNAlater or an equivalent reagent to optimally preserve the RNA. Tissue is left in RNAlater at room temperature for 24 h and then frozen at À 20 1C to undergo RNA isolation and for microarray or next-generation sequencing.
Biomarkers
Biomarkers are measurable indicators of a process, for example bone formation or bone resorption that can be tested for in blood or other body fluids. Post-ablated, regenerated medullary contents or peri-implant tissue are two additional tissues that can be used to test for biomarker concentrations. If blood is used, it is typically collected in vivo via the tail vein or while killing via a cardiac puncture. Blood is then centrifuged to separate the serum from blood solids and serum samples are stored at À 20 1C until analyzed. 38 
Conclusion
This protocol provides a detailed description of the mechanical marrow ablation model as used in rodents for various applications. The mechanical marrow ablation technique provides a reproducible platform specific to studying intramembranous bone regeneration, post-injury bone healing, implant fixation or biomaterial performance. Publishing detailed protocols for techniques like this provides uniformity and helps ensure repeatability in method across laboratories. This will ultimately establish a standard which provides value in evaluating results across studies.
